Purpose:
The
goal
of
the
study
was
to
test
the
efficacy
of
novel
compounds
(rosiglitazone)
in
a
diabetic
mouse
model
BKS.Cg-Dock7m
+/+
Leprdb/J
strain
fed
glucose.
By
posting
this
data,
JAX®
In
Vivo
Services
contributes
to
community
research
resources
and
fulfills
an
agreement
with
clients
to
make
normative
data
public.
Investigator's
notes
and
website:
Compound
evaluation
services:
Obesity
and
type
2
diabetes
Available
download:
Protocol
Data:
Jaxwest7.xls
